The past, present, and future of immunotherapy for endometrial adenocarcinoma

Incidences of endometrial adenocarcinoma are increasing in the USA with poor prognosis for patients with advanced disease. The current treatment standard is surgery including total hysterectomy and bilateral oophorectomy with surgical staging and adjunct treatment, such as chemotherapy or radiation....

Full description

Saved in:

Bibliographic Details
Published in:	Medical oncology (Northwood, London, England) Vol. 40; no. 7; p. 186
Main Authors:	Jones, Anna C., Brown, Karah H., Guan, Tianyun, Smith, Luke A., Formslag, Cole R., Farjado, Emerson D., Bai, Qian, Luechtefeld, Harrison D., Wakefield, Mark R., Dong, Lijun, Fang, Yujiang
Format:	Journal Article
Language:	English
Published:	New York Springer US 23-05-2023 Springer Nature B.V
Subjects:	Adenocarcinoma Antibodies Cancer therapies Cells Cytotoxicity Endometrial cancer Female Hematology Humans Hysterectomy Immune system Immunotherapy Immunotherapy, Adoptive Internal Medicine Kinases Ligands Medical prognosis Medicine Medicine & Public Health Metabolism Metastasis Oncology Pathology Review Article Surgery Tumors Vaccination Vaccines Yeast Endometrial cancer Immunotherapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!